Redox mechanisms at the glutamate synapse and their significance: A review

European Journal of Pharmacology

Volumn 370, Issue 1, 1999, Pages 1-7

  Smythies, John ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Brain Percept Lab Ctr Brain C   (United States)

Author keywords

Antioxidant; Catecholamine o quinone; Glutamate synapse; Nitric oxide (NO); Prostaglandin H synthase 2; Reactive oxygen species

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CARNOSINE; CATECHOLAMINE DERIVATIVE; DOPAMINE; DOPAMINE 2 RECEPTOR; FREE RADICAL; GLUTAMATE RECEPTOR; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROMELANIN; NITRIC OXIDE; PROSTAGLANDIN SYNTHASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOCTIC ACID;

HUMAN; LEARNING; MODULATION; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NEUROTOXICITY; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE;

EID: 0032950897     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00048-5     Document Type: Review

References (87)

1. Aizenman E., Lipton S.A., Loring R.H. Selective modulation of NMDA responses by reduction and oxidation. Neuron. 2:1989;1257-1263.
2. Aoki C., Rhee J., Lubin M., Dawson T.M. NMDA-R1 subunit of the cerebral cortex co-localizes with neuronal nitric oxide synthase at the pre- and postsynaptic sites and in spines. Brain Res. 750:1997;25-40.
3. Bains J.S., Ferguson A.V. Nitric oxide regulates NMDA-driven GABAergic inputs to type I neurons of the rat paraventricular nucleus. J. Physiol. 499(3):1997;733-746.
4. Baez S., Segura-Aguilar J., Widersten M., Johansson A.S., Mannervik B. Glutathione transferases catalyze the detoxification of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem. J. 324:1997;25-28.
5. Beaudet A., Descarries L. The monoamine innervation of rat cerebral cortex: synaptic and non-synaptic terminals. Neuroscience. 3:1978;851-860.
6. Ben-Shachar D., Zuk R., Glinka Y. Dopamine neurotoxicity: inhibition of mitochondrial respiration. J. Neurochem. 64:1995;718-723.
7. Bindokas V.P., Jordán J., Lee C.C., Miller R.J. Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine. J. Neurosci. 16:1996;1324-1336.
8. Böhm F., Edge R., Land E.J., McGarvey D.J., Truscott T.G. Caretenoids enhance vitamin E antioxidant efficiency. J. Am. Chem. Soc. 119:1997;621-627.
9. Boldyrev A.A., Stvolinsky S.L., Tyulina O.V., Koshelev V.B., Hori N., Carpenter D.O. Biochemical and physiological evidence that carnosine is an endogenous neuroprotector against free radicals. Cell. Mol. Neurobiol. 17:1997;259-271.
10. Breder C.D., Dewitt D., Kraig R.P. Characterization of inducible cyclooxygenase in rat brain. J. Comp. Neurol. 355:1995;296-315.
11. Bruno V., Copani A., Bonanno L., Knoepfel T., Kuhn R., Roberts P.J., Nicoletti F. Activation of group III metabotropic glutamate receptors is neuroprotective in cortical cultures. Eur. J. Pharmacol. 310:1996;61-66.
12. Cadet J.L., Kahler L.A. Free radical mechanisms in schizophrenia and tardive dyskinesia. Neurosci. Biobehav. Rev. 18:1994;457-467.
13. Carstam R., Brinck C., Hindemith-Augustsson A., Rorsman H., Rosengren E. The neuromelanin of the human substantia nigra. Biochim. Biophys. Acta. 1097:1991;152-160.
14. Chan A.C. Partners in defense, vitamin E and vitamin C. Can. J. Physiol. Pharmacol. 71:1993;725-731.
15. Cheng F.-C., Kuo J.-S., Chia L.-G., Dryhurst G. Elevated 5-S-cysteinyldopamine/homovanillic acid ratio and reduced homovanillic acid in cerebrospinal fluid: possible markers for and potential insights into the pathoetiology of Parkinson's disease. J. Neural Trans. 103:1996;433-446.
16. Cook J.A., Wink D.A., Blount V., Krishna M.C., Hanbauer I. Role of antioxidants in the nitric oxide-elicited inhibition of dopamine uptake in cultured mesencephalic neurons. Insights into potential mechanisms of nitric oxide-mediated neurotoxicity. Neurochem. Int. 28:1996;609-617.
17. Costa C., Bertazzo A., Allegri G., Toffano G., Curcurato O., Traldi P. Melanin biosynthesis from dopamine: II. A mass spectrometric and collisional spectroscopic investigation. Pigment Cell Res. 5:1992;122-131.
18. Coyle J.T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262:1993;689-695.
19. Cuénod M., Do K.Q., Lauer C.J., Holsboer F. Could a glutathione model integrate both dopamine and glutamate hypothesis of schizophrenia? Biol. Psychiatr. 42:1997;287S.
20. Dawson V.L., Dawson T.M. Nitric oxide actions in neurochemistry. Neurochem. Int. 29:1996;97-110.
21. Dismukes K. New look at the aminergic nervous system. Nature. 269:1977;557-558.
22. Double K.L., Maywald M., Schmittel M., Riederer P., Gerlach M. In vitro studies of ferritin iron release and neurotoxicity. J. Neurochem. 70:1998;2492-2499.
23. Dugan L.L., Creedon D.J., Johnson E.M. Jr., Holtzman D.M. Rapid suppression of free radical formation by nerve growth factor involves the mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. U.S.A. 94:1997;4086-4091.
24. Dumartin B., Caillé I., Gonon F., Bloch B. Internalization of D1 dopamine receptor in striatal neurons in vivo as evidence of activation by dopamine agonists. J. Neurosci. 18:1998;1650-1661.
25. Dykens J.A., Stern A., Trenkner E. Mechanism of kainate toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury. J. Neurochem. 49:1987;1222-1228.
26. Edelman G.M., Gally J.A. Nitric oxide: linking space and time in the brain. Proc. Natl. Acad. Sci. U.S.A. 89:1992;11651-11652.
27. Favit A., Sortino M.A., Aleppo G., Scapagnini U., Canonico P.L. Protection by dihydroergocryptine of glutamate-induced neurotoxicity. Pharmacol. Toxicol. 73:1993;224-228.
28. Fornstedt B., Carlsson A. Vitamin C deficiency facilitates 5-S-cysteinyldopamine formation in guinea pig striatum. J. Neurochem. 56:1991;407-414.
29. Garey L.J., Ong U.Y., Patel T.S., Kanami M., Davis A., Hornstein C., Bauer M. Reduction in dendritic spine number on cortical neurons in schizophrenia. Abstr. Soc. Neurosci. 21:1995;236.
30. Garey L.J., Ong W.Y., Patel T.S., Kanani M., Davis A., Mortimer A.M., Barnes T.R.E., Hirsch S.R. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J. Neurol. Neurosurg. Psychiatr. 65:1998;446-453.
31. Glantz L.A., Lewis D.A. Assessment of spine density on layer III pyramidal cells in the prefrontal cortex of schizophrenic subjects. Abstr. Soc. Neurosci. 21:1995;239.
32. Graham D.G. On the origin and significance of neuromelanin. Arch. Pathol. Lab. Med. 103:1979;359-362.
33. Grasbon-Frodl E.M., Brundin P. Mesencephalic neuron death induced by congeners of nitrogen monoxide is prevented by the lazaroid U 83836E. Exp. Brain Res. 113:1997;138-143.
34. Grünewald R.A. Ascorbic acid in the brain. Brain Res. Rev. 18:1993;123-133.
35. Gutteridge J.M.C. Ferrous ions detected in cerebrospinal fluid by using bleomycin and DNA damage. Clin. Sci. 82:1992;315-320.
36. Harris K.M., Kater S.B. Dendritic spines: cellular specializations imparting both stability and flexibility to synaptic function. Ann. Rev. Neurosci. 17:1994;341-371.
37. Hawley M.D., Tatawawdi S.V., Pietavski S., Adams R.N. Electrochemical studies of the oxidation pathways of catecholamines. J. Am. Chem. Soc. 89:1967;447-450.
38. Hevroni D., Rattner A., Bundman M., Lederfein D., Gabarah A., Mangelus M., Silverman M.A., Kedah H., Noar C., Kornuc M., Hanoch T., Seger R., Theill L.E., Nederi E., Richter-Levin G., Cutri Y. Hippocampal plasticity involves extensive gene induction and multiple cellular mechanisms. J. Mol. Neurosci. 10:1998;76-98.
39. Hirata H., Asanuma M., Cadet J.L. Superoxide radicals are mediators of the effects of methamphetamine on Zi268 (Egr-1, NGF1-A) in the brain: evidence from using CuZn superoxide dismutase transgenic mice. Mol. Brain Res. 58:1998;209-216.
40. Hirsch E.C., Hunot S., Damier P., Farcheux B. Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration? Ann. Neurol. 44(S1):1998;S115-S120.
41. Hoffman R.E., McGlashan T.H. Parallel distributed processing and the emergence of schizophrenic symptoms. Schizophr. Bull. 19:1993;119-140.
42. Hom D.G., Jiang D., Hong E.-T., Mo J.Q., Andersen J.K. Elevated expression of glutathione peroxidase in PC12 cells results in protection against methamphetamine but not MPTP toxicity. Mol. Brain Res. 46:1997;154-160.
43. Hoyt K.R., Gallagher A.J., Hastings T.G., Reynolds I.J. Characterization of hydrogen peroxide toxicity in cultured rat forebrain cells. Neurochem. Res. 22:1997;333-340.
44. Kang M.Y., Tsuchiya M., Packer L., Manabe M. In vitro study on the antioxidant potential of various drugs used in the preoperative period. Acta Anaesthesiol. Scand. 42:1998;4-12.
45. Koenig J.A., Edwardson J.M. Endocytosis and recycling of G protein-coupled receptors. TI Pharmacol. Sci. 18:1997;276-287.
46. Kolodecik T.R., Aten R.F., Behrman H.R. Ascorbic acid-dependent cytoprotection of ovarian cells by leukocyte and nonleukocyte peroxidases. Biochem. Pharmacol. 55:1998;1497-1503.
47. Koppenol W.H. The basic chemistry of nitrogen monoxide and peroxynitrite. Free Rad. Biol. Med. 25:1998;385-391.
48. Kötter R. Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum. Prog. Neurobiol. 44:1994;163-196.
49. Kullmann D.M., Erdemli G., Asztély F. LTP of AMPA and NMDA receptor-mediated signals: evidence for presynaptic expression and extrasynaptic glutamate spill-over. Neuron. 17:1996;461-474.
50. Lafon-Cazal M., Pietri S., Culcasi M., Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature. 364:1993;535-537.
51. Lieb K., Andrae J., Reisert I., Pilgrim C. Neurotoxicity of dopamine and protective effects of the NMDA receptor antagonist AP-5 differ between male and female dopaminergic neurons. Exp. Neurol. 134:1995;222-229.
52. Liu J., Mori A. Monoamine metabolism provides an antioxidant defense in the brain against oxidant- and free radical-induced damage. Arch. Biochem. Biophys. 302:1994;118-127.
53. Lutzenberger W., Stevens A., Bartels M. Do schizophrenics not differentiate between perception and imagination? An EEG study using dimensional analysis. Neurosci. Lett. 199:1995;119-122.
54. Maeda T., Cheng N., Kume T., Kaneko S., Kuchiyama H., Akaike A., Ueda M., Satoh M., Goshima Y., Misu Y. L-DOPA neurotoxicity is mediated by glutamate release in cultured rat striatal neurons. Brain Res. 771:1997;159-162.
55. Mattammal M.B., Strong R., Lakshmi V.M., Chung H.D., Stephenson A.H. Prostaglandin H synthetase-mediated metabolism of dopamine: implication for Parkinson's disease. J. Neurochem. 6:1995;1645-1654.
56. Michel P.P., Hefti F. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J. Neurosci. Res. 26:1990;428-435.
57. Napolitano A., Memoli S., Nappi A.J., d'Ischia M., Prota G. 5-S-cysteinyldopa, a diffusible product of melanocyte activity, is an efficient inhibitor of hydroxylation/oxidation reactions induced by the Fenton system. Biochim. Biophys. Acta. 1291:1996;75-82.
58. Odh G., Carstam R., Paulson J., Wittbjer A., Rosengren E., Rorsman H. Neuromelanin of the human substantia nigra: a mixed type melanin. J. Neurochem. 62:1994;2030-2036.
59. Patel M., Day B.J., Crapo J.D., Fridovich I., McNamara J.O. Requirement for superoxide in excitotoxic cell death. Neuron. 16:1996;345-355.
60. Pickel V.M., Nirenberg M.J., Milner T.A. Ultrastructural view of central catecholaminergic transmission: immunocytochemical localization of synaptic enzymes, transporters and receptors. J. Neurocytol. 25:1997;843-856.
61. Quartz S.R., Sejnowski T.J. The neural basis of cognitive development: a constructivist manifesto. Behav. Brain Sci. 20:1997;537-556.
62. Quesada O., Hirsch J., Ben-Ari Y., Bernard C. Redox sites of NMDA receptor can modulate epileptiform activity in hippocampal slices from kainic acid-treated rats. Neurosci. Lett. 212:1996;171-174.
63. Rebec G.V., Pierce R.C. A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Prog. Neurobiol. 43:1994;537-565.
64. Rebec G.V., Grabner C.P., Johnson M., Pierce R.C., Bardo M.T. Transient increases in catecholaminergic activity in medial prefrontal cortex and nucleus accumbens shell during novelty. Neuroscience. 76:1997;707-714.
65. Roberts R.C., Gauther L.A., Peretti F., Peretti F.J., Chute D.J. Structural pathology in schizophrenia: a postmortem ultrastructural study. Abstr. Soc. Neurosci. 21:1995;237.
66. Rothman S.M., Olney J.W. Excitotoxicity and the NMDA receptor - still lethal after eight years. TINS. 18:1995;57-58.
67. Sagara Y., Schubert D. The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress. J. Neurosci. 18:1998;6662-6671.
68. Sam E.E., Verbeke N. Free radical scavenging properties of apomorphine enantiomers and dopamine: possible implication in their mechanism of action in parkinsonism. J. Neural Trans. Parkinson's Disease and Dementia Section. 10:1995;115-127.
69. Sampath D., Perez-Polo R. Regulation of antioxidant enzyme expression by NGF. Neurochem. Res. 22:1997;351-362.
70. Sawada H., Ibi M., Kihara T., Urushitani M., Akaike A., Kimura J., Shimohama S. Dopamine D2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: mechanisms of neuroprotective treatment against oxidative stress. Ann. Neurol. 44:1998;110-119.
71. Schultz W. Dopamine neurons and their role in reward mechanisms. Curr. Opin. Neurobiol. 7:1997;191-197.
72. Sesack S.R., Pickel V.M. In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other. Brain Res. 527:1990;266-279.
73. Smythies J.R. On the function of neuromelanin. Proc. R. Soc. London B. 263:1996;487-489.
74. Smythies J.R. The biochemical basis of synaptic plasticity and neurocomputation: a new theory. Proc. R. Soc. London B. 264:1997;575-579.
75. Smythies J.R. Oxidative reactions and schizophrenia: a review-discussion. Schizophr. Res. 24:1997;357-364.
76. Smythies, J.R., 1998. The neurochemical basis of learning and neurocomputation: the Redox Theory. Behav. Brain Res., in press.
77. Sossin W.S. Mechanisms for the generation of synaptic specificity in long-term memory: the implications of a requirement for transcription. TINS. 19:1996;215-218.
78. Suzuki Y.J., Forman H.J., Sevanian A. Oxidants as stimulators of signal transduction. Free Rad. Biol. Med. 22:1997;269-285.
79. VanderWende C., Johnson J.C. Interaction of serotonin with the catecholamines: I. Inhibition of dopamine and norepinephrine oxidation. Biochem. Pharmacol. 19:1970;1991-2000.
80. VanderWende C., Johnson J.C. Interaction of serotonin with the catecholamines: II. Activation and inhibition of adrenochrome formation. Biochem. Pharmacol. 19:1970;2001-2007.
81. Vickery R.G., Christine C., von Zastrow M. Subtype-specific differences in dopamine receptor endocytosis. Abstr. Soc. Neurosci. 24:1998;23.
82. Wink D.A., Mitchell J.B. Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Rad. Biol. Med. 25:1998;434-456.
83. Yan X.X., Garey J.J. Morphological diversity of nitric oxide synthesizing neurons in mammalian cerebral cortex. J. Hirnforsch. 38:1997;165-172.
84. Yen G.C., Hsieh C.L. Antioxidant effects of dopamine and related compounds. Biosci. Biotech. Biochem. 61:1997;1646-1649.
85. 2-induced apoptosis in human neuronal cells. Biochem. Biophys. Res. Commun. 235:1997;845-848.
86. Zhao Z.S., Khan S., O'Brien P.J. Catecholic iron complexes as cytoprotective superoxide scavengers against hypoxia:reoxygenation injury in isolated hepatocytes. Biochem. Pharmacol. 56:1998;825-830.
87. 2+. J. Neurochem. 64:1995;2552-2558.